SkinBioTherapeutics's market cap is currently £45.69M. The company's EPS TTM is p-0.015; its P/E ratio is ―; SkinBioTherapeutics is scheduled to report earnings on April 1, 2025, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 24	Jun 23	Jun 22	Jun 21	Jun 20
Income Statement
Total Revenue	£ 1.21M	£ 132.06K	£ 74.76K	£ 0.00	£ 0.00
Gross Profit	£ 683.04K	£ 85.19K	£ 15.91K	£ -5.05K	£ -5.10K
Operating Income	£ -2.91M	£ -3.00M	£ -2.98M	£ -1.49M	£ -1.62M
EBITDA	£ -2.72M	£ -2.96M	£ -2.95M	£ -1.49M	£ -1.61M
Net Income	£ -2.88M	£ -2.84M	£ -2.79M	£ -1.43M	£ -1.50M
Balance Sheet
Cash & Short-Term Investments	£ 800.90K	£ 1.31M	£ 1.80M	£ 4.61M	£ 2.16M
Total Assets	£ 5.22M	£ 2.59M	£ 3.08M	£ 5.73M	£ 2.77M
Total Debt	£ 818.74K	£ 100.65K	£ 127.86K	£ 139.85K	£ 0.00
Net Debt	£ 17.84K	£ -1.21M	£ -1.68M	£ -4.47M	£ -2.16M
Total Liabilities	£ 2.25M	£ 599.34K	£ 609.61K	£ 519.67K	£ 304.83K
Stockholders' Equity	£ 2.97M	£ 1.99M	£ 2.48M	£ 5.22M	£ 2.47M
Cash Flow
Free Cash Flow	£ -2.92M	£ -2.81M	£ -2.77M	£ -1.67M	£ -965.80K
Operating Cash Flow	£ -2.73M	£ -2.65M	£ -2.67M	£ -1.56M	£ -892.14K
Investing Cash Flow	£ -2.30M	£ -165.28K	£ -96.81K	£ -112.31K	£ -73.67K
Financing Cash Flow	£ 4.51M	£ 2.32M	£ -35.12K	£ 4.12M	£ 0.00

Currency in GBP

SkinBioTherapeutics Earnings and Revenue History

Income Statement >

SkinBioTherapeutics Debt to Assets

Balance Sheet >

SkinBioTherapeutics Cash Flow

Cash Flow >

SkinBioTherapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing